S3v Vascular Technologies Limited Unlisted Shares - Company Overview

S3v Vascular Technologies Limited is a Public company incorporated on 09 Dec 2011. It is classified as Non-government company and is registered at Registrar of Companies, Bangalore. Its authorized share capital is Rs. 250000000 and its paid up capital is Rs. 191785900.

S3V Vascular Technologies develops and manufactures innovative, affordable, minimally invasive medical devices for cardiovascular and neurological conditions, focusing on stents (drug-eluting, bare-metal), catheters (PTCA, aspiration, neuro), guidewires, and stroke intervention systems (stent retrievers), aiming to make advanced therapies accessible in India and globally by replacing expensive imports with high-quality, indigenous solutions. They're creating a full suite for neuro-intervention, including next-gen devices like nickel-cobalt-free stents, and building an integrated manufacturing ecosystem.

S3v Vascular Technologies Limited Share Price, Share Details as of March 31, 2025

S3v Vascular Technologies Limited Incorporation Details

S3v Vascular Technologies Limited Board of Directors

S3v Vascular Technologies Ltd Principal Business Activities

Q: What is the face value of S3V Vascular Technologies Ltd shares?
Answer: The face value of S3V Vascular Technologies Ltd is ₹10 per equity share.

Q: What is the minimum lot size for buying S3V Vascular Technologies shares through WWIPL?
Answer: The minimum lot size for S3V Vascular Technologies shares is 100 equity shares.

Q: How can I buy S3V Vascular Technologies unlisted shares through WWIPL?
Answer: Investors can complete the KYC process, confirm the transaction details with WWIPL, transfer funds, and receive shares directly in their Demat account.

Q: Why should I buy S3V Vascular Technologies shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in S3V Vascular Technologies Ltd a good idea?
Answer: Investors often evaluate S3V Vascular Technologies based on its presence in the high-growth medical devices sector, product portfolio, innovation capabilities, and long-term healthcare demand.

Q: Why do investors buy S3V Vascular Technologies shares before a potential IPO?
Answer: Investors seek early exposure to a medical technology company before listing, aiming to participate in future value creation and potential liquidity opportunities.

Q: What business does S3V Vascular Technologies Ltd operate in?
Answer: S3V Vascular Technologies develops, manufactures, and markets cardiovascular and vascular medical devices used in interventional cardiology, radiology, and peripheral vascular procedures.

Q: What makes S3V Vascular Technologies different from other unlisted healthcare companies?
Answer: The company operates in the specialized medical devices segment and focuses on indigenous development of vascular intervention products, reducing dependence on imported medical equipment.

Q: What are the key growth drivers for S3V Vascular Technologies Ltd?
Answer: Rising cardiovascular disease incidence, increasing healthcare expenditure, growth in medical device adoption, and government support for domestic medical manufacturing are key growth drivers.

Q: What factors affect the valuation of S3V Vascular Technologies shares?
Answer: Revenue growth, profitability, product approvals, manufacturing capabilities, market penetration, and expansion into new healthcare segments are key valuation drivers.

Q: Are S3V Vascular Technologies shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my S3V Vascular Technologies shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and share availability.

Q: What documents are required to buy S3V Vascular Technologies shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report (CMR), and bank account details to complete the transaction.

Q: What are the risks of investing in S3V Vascular Technologies shares?
Answer: Investors should consider regulatory approval risks, competition from global medical device manufacturers, technology obsolescence, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track S3V Vascular Technologies investments?
Answer: WWIPL provides company updates, transaction assistance, market information, and investment insights to help investors stay informed.

Q: How long does it take for S3V Vascular Technologies shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in S3V Vascular Technologies Ltd?
Answer: Investors should assess the company's financial performance, product portfolio, regulatory approvals, manufacturing capabilities, valuation, and long-term growth prospects.

Q: Can S3V Vascular Technologies benefit from India's growing medical devices market?
Answer: Yes. Rising healthcare investments, increasing demand for advanced medical devices, and government initiatives promoting domestic manufacturing may create significant long-term growth opportunities for the company.